Copy For Citation
Cobanoglu N., Ozcelik U., ÇAKIR E., Eyuboglu T. S., PEKCAN S., Cinel G., ...More
Pediatric pulmonology, vol.55, no.9, pp.2302-2306, 2020 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
55
Issue:
9
-
Publication Date:
2020
-
Doi Number:
10.1002/ppul.24854
-
Journal Name:
Pediatric pulmonology
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Page Numbers:
pp.2302-2306
-
Çukurova University Affiliated:
Yes
Abstract
Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacaftor-tezacaftor-ivacaftor. This cross-sectional study evaluated cystic fibrosis (CF) patients eligible for modulator drugs.